PTGS2 and endometrium neoplasm: The COX2 expression level can serve as a prognostic marker for targeted treatment and indicate the degree of endometrial tumor invasion into the myometrium.[7] Along with the pro-oncogenic properties of COX2, there is evidence of its tumor-suppressive effect.